Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: MJNA

AXIM IBS Treatment Options and Market Growth in 2017 and Beyond

AXIM

Irritable bowel syndrome is a chronic condition characterized by discomfort and pain in the abdominal region. Sufferers also experience symptoms such as diarrhea, constipation and gas, and it is believed that the condition is adversely affected by anxiety. Anywhere between 25 and 45 million people are affected by IBS in the United States alone, and 2 out of 3 IBS patients are women. The unfortunate reality for IBS sufferers is that there are few effective long-term treatments that manage symptoms without the risk of side effects. As a result, the IBS market presents plenty of opportunities for alternative treatment methods to make a positive impact on patients worldwide.

Medical Marijuana Products

Pharmaceutical industry experts predict that the market for cannabis products could reach 10 percent of the specialty market by the year 2020, with a market value of $20 billion. With a variety of cannabinoids to test and incorporate …

Continue Reading

Posted in Articles| Tagged , , , , |

MJNA Starts Where it Left off in 2016 with Big International Growth

HempMeds

To say that Medical Marijuana, Inc. made headlines in 2016 would be an understatement. In reality, the company known for its CBD hemp oil products took the medical marijuana market by storm with product availability in all 50 states. Since its launch in 2012, MJNA‘s subsidiary company, HempMeds, has made it easier for patients around the country to access relief for a variety of medical issues without the debilitating side effects that often accompany traditional treatment methods. In 2015, the market for hemp products in the United States climbed to $573 million, and that figure is expected to increase dramatically over the next several years. According to estimates from the Hemp Business Journal, the market for CBD is expected to reach $2.1 billion by 2020.

MJNA’s Subsidiary Companies

MJNA‘s subsidiaries include HempMeds, Kannaway, HempMeds MX and HempMeds Brasil. Each of these subsidiaries serves a unique segment of the cannabis …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR

Partnership to Provide Expanded Accessibility to RSHO™, the First-Ever Product Approved for Import by Brazilian Government

SAN DIEGO, CA–(Marketwired – January 05, 2017) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.

The partnership between HempMeds® Brasil and Paragon HealthCare BR will provide countless individuals in need of hemp-based medical service more accessibility to HempMeds® Brasil’s Real Scientific Hemp Oil™ (RSHO™) line of products. Both pioneers in their respective industries, this newfound partnership provides the opportunity to expose the world to a growing range of products that are showing therapeutic value in international markets.

“This new collaboration with Paragon HealthCare BR is another victory for the hemp industry, and most importantly, for the consumer,” said Chief Executive Officer …

Continue Reading

Posted in Client News| Tagged , , , |

Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations

Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin America

SAN DIEGO, CA–(Marketwired – December 29, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its subsidiary HempMeds® Mexico and its products were featured in an L.A. Weekly article focused on the first-ever import permit granted by Mexico for the cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™).

The Dec. 23, 2016, article titled “Mexico Begins Importing Medical Marijuana As Views on Therapeutic Cannabis Evolve” states, “The California-based company’s partnership with Mexico — an ally of particular interest thanks to cultural and historical ties that date back centuries — was solidified earlier this year when COFEPRIS, the Mexican health department, approved the country’s first permit allowing the import of hemp-based CBD oil across its border.” The article goes on …

Continue Reading

Posted in Client News| Tagged , , , |

Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlights Historic Year

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming Year

SAN DIEGO, CA–(Marketwired – December 28, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE. As you can view HERE, Medical Marijuana, Inc. has long been “A Company of Firsts.” 2016 continued to show the company’s progress with many firsts including; receiving the first-ever import permit from the Mexican federal government, receiving the world’s first patented cannabinoid controlled-release chewing gum and becoming the first-ever DEA permit granted to a US-based company to import pharmaceutical grade cannabidiol. Additionally, they participated in first-ever events like the Doctors Symposium in Mexico, ExpoMede Weed in Medellin, Colombia and Genesis in San Diego.

This recap highlights various exciting business activities and developments within Medical Marijuana, Inc.’s …

Continue Reading

Posted in Client News| Tagged , , , |

How MJNA is Taking Hold of the Massive and Growing CBD Market Worldwide

Medical Marijuana, Inc. (OTC: MJNA)

The market for non-THC CBD hemp oil products has grown rapidly since 2012, when MJNA’s subsidiary HempMeds first began. Since that time, Medical Marijuana, Inc. (OTC: MJNA) and its other subsidiaries have seen remarkable success when it comes to clinical research, public and institutional education and sales. According to the Hemp Industries Association, the 2015 hemp product market reached $573 million in the United States alone. Hemp-derived cannabidiol products make up an impressive 11 percent of those sales, totaling an estimated $65 million. Medical Marijuana, Inc. can claim a significant number of those sales through its targeted subsidiary companies and are legally available in all 50 states. Read on for a look at how each of these companies under the MJNA umbrella has changed the CBD market.

HempMeds

HempMeds is a CBD hemp oil product distribution company with a global reach. The company focuses on producing a variety of …

Continue Reading

Posted in Articles| Tagged , , , |